Displaying 21 to 40 of 48 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
KYTHERA Biopharmaceuticals Inc |
United States | 1 May 2008 | Series C |
|
|
|
KYTHERA Biopharmaceuticals Inc |
United States | 1 Sep 2011 | Series D |
|
|
|
Lux Biosciences Inc Clinical stage biotechnology company specializing in the development and commercialization of innovative medications for serious ophthalmic diseases. |
United States | N/A |
||
|
Nanosys Inc Nanotechnology-enabled systems |
United States | N/A Active |
||
|
Neomend Inc A biomedical device company, engages in the development and commercialization of surgical wound healing products |
United States | 1 Jan 2010 | Series D Active |
|
|
|
NGM Biopharmaceuticals Inc Biopharmaceutical company focused on the discovery and development of breakthrough therapeutics for metabolic diseases. |
United States | N/A |
||
|
|
NinePoint Medical Inc A transformational medical device company, develops in vivo pathology medical devices. |
United States | N/A |
||
|
|
Nora Therapeutics Inc Specialty biopharmaceutical company that focuses on developing therapeutics to address clinical unmet needs in reproductive medicine. |
United States | N/A |
||
|
|
Novacept Inc Commercializing innovative medical devices to improve the quality and cost-effectiveness of healthcare for women. |
United States | N/A |
||
|
|
Opus Medical Inc Minimally invasive techniques for orthopedic surgery. |
United States | N/A |
||
|
|
Panmira Pharmaceuticals LLC Pharmaceutical company for inflammatory diseases. |
United States | N/A |
||
|
|
Pathwork Diagnostics Inc |
United States | 1 Jul 2006 | N/A |
|
|
|
Phylogix Inc Biotechnology company focused on tissue protection and oncology. |
United States | Series B |
||
|
|
Portola Pharmaceuticals Inc |
United States | N/A Active |
||
|
|
Rinat Neuroscience Corp Discovers and commercializes novel antibody based drugs and drug targets for the major mental and neuro-degenerative diseases |
United States | 1 Aug 2003 | Series B Initial investment. Round participant. Active |
|
|
|
Roxro Pharma Inc Develops drugs for pain treatment |
United States | 1 Jun 2007 | Series B |
|
|
|
Senomyx Inc Discovery and development of innovative flavor ingredients for the food, beverage, and ingredient supply industries |
United States | N/A Active |
||
|
|
SentreHEART Inc A medical device company that has developed catheter-based solutions to address unmet clinical needs. |
United States | 1 Jun 2012 | Series C Initial investment. Round participant. Active |
|
|
|
Somaxon Pharmaceuticals Inc |
United States | N/A |
||
|
|
Tercica Inc A biopharmaceutical company developing new therapeutics for endocrine system disorders. |
United States | N/A |